Amino acid 36 in the human immunodeficiency virus type 1 gp41 ectodomain controls fusogenic activity: implications for the molecular mechanism of viral escape from a fusion inhibitor

Amino acid 36 in the human immunodeficiency virus type 1 gp41 ectodomain controls fusogenic activity: implications for the molecular mechanism of viral escape from a fusion inhibitor

Item
http://www.wikidata.org/entity/Q33780643
HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomesAll APOBEC3 family proteins differentially inhibit LINE-1 retrotranspositionTwo N-linked glycosylation sites in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 regulate viral neutralization susceptibility to the human monoclonal antibody specific for the CD4 binding domainMultiple sites in the N-terminal half of simian immunodeficiency virus capsid protein contribute to evasion from rhesus monkey TRIM5α-mediated restriction.The carboxyl-terminus of human immunodeficiency virus type 2 circulating recombinant form 01_AB capsid protein affects sensitivity to human TRIM5α.CRF01_AE-specific neutralizing activity observed in plasma derived from HIV-1-infected Thai patients residing in northern Thailand: comparison of neutralizing breadth and potency between plasma derived from rapid and slow progressors.Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus.Human immunodeficiency virus type 1 variants resistant to first- and second-version fusion inhibitors and cytopathic in ex vivo human lymphoid tissue.A single amino acid of the human immunodeficiency virus type 2 capsid affects its replication in the presence of cynomolgus monkey and human TRIM5alphasHighly conserved configuration of catalytic amino acid residues among calicivirus-encoded proteases.Role of HIV Gp41 mediated fusion/hemifusion in bystander apoptosis.An HIV/AIDS Prophylactic vaccine is possible.SC29EK, a peptide fusion inhibitor with enhanced alpha-helicity, inhibits replication of human immunodeficiency virus type 1 mutants resistant to enfuvirtideImpact of amino acid substitutions in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 on viral neutralization susceptibility to broadly neutralizing antibodies specific for the CD4 binding site.MARCH8 inhibits HIV-1 infection by reducing virion incorporation of envelope glycoproteins.Site-specific Mutations in HIV-1 gp41 Reveal a Correlation between HIV-1-mediated Bystander Apoptosis and Fusion/Hemifusion
P2860

Amino acid 36 in the human immunodeficiency virus type 1 gp41 ectodomain controls fusogenic activity: implications for the molecular mechanism of viral escape from a fusion inhibitor

Item
http://www.wikidata.org/entity/Q33780643
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Amino acid 36 in the human imm ...... escape from a fusion inhibitor
@ast
Amino acid 36 in the human imm ...... escape from a fusion inhibitor
@en
type
label
Amino acid 36 in the human imm ...... escape from a fusion inhibitor
@ast
Amino acid 36 in the human imm ...... escape from a fusion inhibitor
@en
prefLabel
Amino acid 36 in the human imm ...... escape from a fusion inhibitor
@ast
Amino acid 36 in the human imm ...... escape from a fusion inhibitor
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Amino acid 36 in the human imm ...... escape from a fusion inhibitor
@en
P2093
P2860
P304
P31
P356
10.1128/JVI.79.10.5996-6004.2005
P433
P478
P50
P577
P698
P932